Discovery of LY2607540: A novel and selective mGluR2 positive allosteric modulator (PAM) demonstrates activity in animal models of anxiety and depression

被引：0
|
作者：
Khilevich, Albert [1 ]
Mayhugh, Daniel R. [1 ]
Hay, David A. [1 ]
Zhang, Deyi [1 ]
Liu, Bin [1 ]
Svensson, Kjell A. [1 ]
Falcone, Julie F. [1 ]
Heinz, Beverly A. [1 ]
Wang, Xushan [1 ]
Witkin, Jeff M. [1 ]
Rassmussen, Kurt [1 ]
Rorick-Kehn, Linda [1 ]
Benvenga, Mark J. [1 ]
Li, Xia [1 ]
Hart, John C. [1 ]
Chaney, Stephen [1 ]
Catlow, John T. [1 ]
Swanson, Steve [1 ]
Schkeryantz, Jeffrey M. [1 ]
机构：
[1] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2013年 / 246卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
87-MEDI
引用
收藏
页数：1
相关论文
共 31 条
  • [1] Discovery of LSN2535717, a selective, orally active mGluR2 positive allosteric modulator (PAM): Lead generation SAR and effects in animal models of anxiety
    Mayhugh, Daniel R.
    Khilevich, Albert
    Knobelsdorf, James A.
    Hay, David A.
    Svensson, Kjell A.
    Falcone, Julie F.
    Swanson, Steve
    Catlow, John T.
    Rorick-Kehn, Linda
    Hart, John C.
    Heinz, Beverly
    Wang, Xushan
    Benvenga, Mark J.
    Chaney, Stephen
    Witkin, Jeffrey M.
    Li, Xia
    Schkeryantz, Jeffrey M.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 246
  • [2] LY2607540 (THIIC): A Novel, Brain Penetrant, Positive Allosteric Modulator of the Metabotropic Glutamate Receptor 2
    Schkeryantz, J.
    Svensson, K.
    Kehn, L. Rorick
    Fell, M.
    Witkin, J. M.
    Felder, C.
    Mayhugh, D.
    Khilevich, A.
    Swanson, S.
    Catlow, J.
    Heinz, B.
    Wang, Xushan
    CURRENT NEUROPHARMACOLOGY, 2011, 9 : 57 - 58
  • [3] A SELECTIVE MGLUR2 POSITIVE ALLOSTERIC MODULATOR RADIOLIGAND DEFINES THE MGLUR2 DISTRIBUTION IN RAT, RHESUS AND HUMAN BRAIN
    Jacobson, Marlene
    Pascarella, D. M.
    Brnardic, E. J.
    Hartingh, T. J.
    O'Brien, J. A.
    Magliaro, B. C.
    Zeng, Z.
    Garbaccio, R. M.
    Converso, A.
    Tang, Y. S.
    Fraley, M. E.
    Hutson, P. H.
    SCHIZOPHRENIA BULLETIN, 2009, 35 : 336 - 336
  • [4] Synthesis and characterization of novel metabotropic glutamate receptor 2/3 (mGluR2/3) positive allosteric modulator (PAM)
    Piotr Brański
    Jakub Staroń
    Ryszard Bugno
    Joanna Wierońska
    Andrzej Bojarski
    Grzegorz Burnat
    Agnieszka Pałucha-Poniewiera
    Andrzej Pilc
    Pharmacological Reports, 2011, 63 (2) : 577 - 577
  • [5] Synthesis and characterization of novel metabotropic glutamate receptor 2/3 (mGluR2/3) positive allosteric modulator (PAM)
    Branski, Piotr
    Staron, Jakub
    Bugno, Ryszard
    Wieronska, Joanna
    Bojarski, Andrzej
    Burnat, Grzegorz
    Palucha-Poniewiera, Agnieszka
    Pilc, Andrzej
    PHARMACOLOGICAL REPORTS, 2011, 63 (02) : 577 - 577
  • [6] Characterization of an mGluR2/3 Negative Allosteric Modulator in Rodent Models of Depression
    Campo, Brice
    Kalinichev, Mikhail
    Lambeng, Nathalie
    El Yacoubi, M.
    Royer-Urios, Isabelle
    Schneider, Manfred
    Legrand, Coline
    Parron, Delphine
    Girard, Francoise
    Bessif, Abdelhak
    Poli, Sonia
    Vaugeois, Jean-Marie
    Le Poul, Emmanuel
    Celanire, Sylvain
    JOURNAL OF NEUROGENETICS, 2011, 25 (04) : 152 - 166
  • [7] Discovery of MK-8768, a Potent and Selective mGluR2 Negative Allosteric Modulator
    Rudd, Michael T.
    Manley, Peter J.
    Hanney, Barbara
    Meng, Zhaoyang
    Shu, Youheng
    de Leon, Pablo
    Frie, Jessica L.
    Han, Yongxin
    Wai, Jenny Miu-Chun
    Yang, Zhi-Qiang
    Perkins, James J.
    Hurzy, Danielle M.
    Manikowski, Jesse J.
    Zhu, Hong
    Bungard, Christopher J.
    Converso, Antonella
    Meissner, Robert S.
    Cosden, Mali L.
    Hayashi, Ikuo
    Ma, Lei
    O'Brien, Julie
    Uebele, Victor N.
    Schachter, Joel B.
    Bhandari, Neetesh
    Ward, Gwendolyn J.
    Fillgrove, Kerry L.
    Lu, Bing
    Liang, Yuexia
    Dubost, David C.
    Puri, Vanita
    Eddins, Donnie M.
    Vardigan, Joshua D.
    Drolet, Robert E.
    Kern, Jonathan T.
    Uslaner, Jason M.
    ACS MEDICINAL CHEMISTRY LETTERS, 2023, 14 (08): : 1088 - 1094
  • [8] Efficacy of an mGluR2 Agonist (LY354740) and an mGluR2 Positive Allosteric Modulator (AZD8529) in Attenuating Ketamine Effects in Humans
    Krystal, John H.
    NEUROPSYCHOPHARMACOLOGY, 2013, 38 : S26 - S26
  • [9] Novel mGluR2 positive allosteric modulators (PAMs): Discovery, SAR development, and in vivo evaluation in antipsychotic models
    Zhang, Lei
    Duplantier, Allen J.
    Efremov, Ivan
    Rogers, Bruce N.
    McHardy, Stanley F.
    Berke, Helen
    Candler, John
    Evrard, Edel
    Kraus, Kenneth
    Maklad, Noha
    O'Sullivan, Theresa J.
    Qian, Weimin
    Rottas, Melinda D.
    Zhang, Qian A.
    Doran, Angela C.
    Haas, Jessica
    Hanks, Ashley M.
    Lazzaro, John T.
    McCarthy, Sheryl A.
    Tingley, F. David
    Siuciak, Judith A.
    Schmidt, Christopher J.
    Ganong, Alan H.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 238
  • [10] Discovery of 4-arylquinoline-2-carboxamides, highly potent and selective class of mGluR2 negative allosteric modulators: From HTS to activity in animal models
    Shu, Youheng
    Diamond, Tracy L.
    Hershey, James C.
    Huang, Shaei
    Magliaro, Brian C.
    O'Brien, Julie A.
    Schlegel, Kelly-Ann S.
    Puri, Vanita
    Uebele, Victor N.
    Uslaner, Jason M.
    Wang, Cheng
    Converso, Antonella
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2020, 30 (09)
1234